PFBT
APGE icon

Parkside Financial Bank & Trust’s Apogee Therapeutics APGE Stock Holding History

Parkside Financial Bank & Trust’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61K Hold
31
– – ﹤0.01% 2019
2025
Q4 		$2.34K Hold
31
– – ﹤0.01% 2045
2025
Q3 		$1.23K Buy
31
+21
+210% +$802 ﹤0.01% 2201
2025
Q2 		$435 Hold
10
– – ﹤0.01% 2609
2025
Q1 		$374 Buy
+10
New +$387 ﹤0.01% 2576

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Parkside Financial Bank & Trust's APGE Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Apogee Therapeutics (APGE) position steady in Q1 2026 at 31 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2019.

Parkside Financial Bank & Trust first reported a position in APGE in Q1 2025 and has held it in 5 quarters since. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Parkside Financial Bank & Trust held 31 shares of Apogee Therapeutics worth $2.61K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Apogee Therapeutics share count unchanged in Q1 2026.
  • Apogee Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2019 holding.
  • Parkside Financial Bank & Trust first reported a position in Apogee Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.